|
|
|
| Predictive value of RDW combined with Hcy in the recurrence of atrial fibrillation after radiofrequency ablation |
| XU Jingping MA Xiaofeng WANG Hong XU Ping |
| Department of Cardiology, Qinghai Provincial Hospital of Cardiovascular and Cerebrovascular Diseases, Qinghai Province, Xining 810000, China |
|
|
|
Abstract Objective To investigate the predictive value of red blood cell distribution width (RDW) combined with homocysteine (Hcy) in the recurrence of atrial fibrillation (hereinafter referred to as atrial fibrillation) after percutaneous radiofrequency catheter ablation (RFCA). Methods From January 2016 to February 2018, 103 patients with atrial fibrillation who underwent RFCA in Qinghai Provincial Hospital of Cardiovascular and Cerebrovascular Diseases were selected. The basic data, blood routine index, biochemical index, and cardiac color Doppler ultrasound were recorded. According to whether RFCA recurrence after three months, the patients were divided into non-recurrence group and recurrence group. The risk factors of postoperative recurrence of atrial fibrillation were analyzed, and receiver operating characteristic (ROC) curve was used to predict the recurrence of atrial fibrillation. Results The mean follow-up time was (17.6±5.7) months, and 13 patients had a recurrence. Left atrial diameter, RDW, total bilirubin, direct bilirubin, uric acid, Hcy, neutrophils, and neutrophil-to-lymphocyte ratio in recurrence group were higher than those in non-recurrence group, and the differences were statistically significant (P＜0.05). RDW and Hcy were independent risk factors for postoperative recurrence of atrial fibrillation (OR＞1, P＜0.05). ROC curve analysis showed that RDW combined with Hcy predicted postoperative recurrence of atrial fibrillation with an area under the curve of 0.797, sensitivity of 69.2%, and specificity of 87.4%. Conclusion RDW and Hcy are independent risk factors for postoperative recurrence of atrial fibrillation. RDW combined with Hcy has high predictive value in the evaluation of postoperative recurrence of atrial fibrillation.
|
|
|
|
|
|
[1] 胡志成，蒋超，郑黎晖，等.2019年中国心房颤动医疗质量控制报告[J].中国循环杂志，2020，35（5）：427-437.
[2] 中国心血管健康与疾病报告编写组.中国心血管健康与疾病报告2020概要[J].中国循环杂志，2021，36（6）：521- 545.
[3] Parameswaran R，Al-Kaisey AM，Kalman JM. Catheter ablation for atrial fibrillation：current indications and evolving technologies [J]. Nat Rev Cardiol，2021，18（3）：210-225.
[4] Wang Z，Korantzopoulos P，Roever L，et al. Red blood cell distribution width and atrial fibrillation [J]. Biomark Med，2020，14（13）：1289-1298.
[5] Dong XJ，Wang BB，Hou FF，et al. Homocysteine（HCY）levels in patients with atrial fibrillation（AF）：A meta-analysis [J]. Int J Clin Pract，2021，75（12）：e14738.
[6] 彭湖，陈柏荣，危小良，等.血浆脂联素、同型半胱氨酸浓度与阵发性心房颤动并发腔隙性脑梗死患者的关系[J].岭南心血管病杂志，2015，21（5）：643-645，649.
[7] Cheung CC，Nattel S，Macle L，et al. Management of Atrial Fibrillation in 2021：An Updated Comparison of the Current CCS/CHRS，ESC，and AHA/ACC/HRS Guidelines [J]. Can J Cardiol，2021，37（10）：1607-1618.
[8] Erhard N，Metzner A，Fink T. Late arrhythmia recurrence after atrial fibrillation ablation：incidence，mechanisms and clinical implications [J]. Herzschrittmacherther Elektrophy- siol，2022，33（1）：71-76.
[9] Harada M，Nattel S. Implications of Inflammation and Fibrosis in Atrial Fibrillation Pathophysiology[J]. Card Electrophysiol Clin，2021，13（1）：25-35.
[10] Noubiap JJ，Sanders P，Nattel S，et al. Biomarkers in Atrial Fibrillation：Pathogenesis and Clinical Implications [J]. Card Electrophysiol Clin，2021，13（1）：221-233.
[11] Benz AP，Aeschbacher S，Krisai P，et al. Biomarkers of Inflammation and Risk of Hospitalization for Heart Failure in Patients With Atrial Fibrillation [J]. J Am Heart Assoc，2021，10（8）：e019168.
[12] Jia L，Cui S，Yang J，et al. Red blood cell distribution width predicts long-term mortality in critically ill patients with acute kidney injury：a retrospective database study [J]. Sci Rep，2020，10（1）：4563.
[13] Wang B，Aihemaiti G，Cheng B，et al. Red Blood Cell Distribution Width Is Associated with All-Cause Mortality in Critically Ill Patients with Cardiogenic Shock [J]. Med Sci Monit，2019，25：7005-7015.
[14] Valenti AC，Vitolo M，Imberti JF，et al. Red Cell Distribution Width：A Routinely Available Biomarker with Important Clinical Implications in Patients with Atrial Fibrillation [J]. Curr Pharm Des，2021，27（37）：3901-3912.
[15] 吴聪，胥茜，石瑞正，等.房颤导管消融术复发的危险因素[J].中南大学学报（医学版），2019，44（10）：1196-1202.
[16] Lippi G，Cervellin G，Sanchis-Gomar F. Red blood cell distribution width：A marker of anisocytosis potentially associated with atrial fibrillation [J]. World J Cardiol，2019， 11（12）：292-304.
[17] Shao Q，Korantzopoulos P，Letsas KP，et al. Red blood cell distribution width as a predictor of atrial fibrillation [J]. J Clin Lab Anal，2018，32（5）：e22378.
[18] Li H，Gu Y，Liu M，et al. The relationship between red blood cell distribution width and atrial fibrillation in Asian population：A cross-sectional study [J]. Pacing Clin Electrophysiol，2019，42（9）：1197-1203.
[19] 陈社安，张漫漫，姜江，等.红细胞分布宽度与心房颤动导管消融术后复发相关性的Meta分析[J].中国循证心血管医学杂志，2020，12（7）：794-797.
[20] 李宏亮，刘彤，许纲，等.红细胞分布宽度与阵发性非瓣膜性心房颤动射频消融后复发的关系[J].天津医科大学学报，2016，22（2）：104-106.
[21] 朱林，洪梅.同型半胱氨酸与心房颤动的研究进展[J].心血管病学进展，2019，40（9）：1216-1219.
[22] Yao Y，Shang MS，Dong JZ，et al. Homocysteine in non- valvular atrial fibrillation：Role and clinical implications [J]. Clin Chim Acta，2017，475：85-90.
[23] Stevenson MD，Canugovi C，Vendrov AE，et al. NADPH Oxidase 4 Regulates Inflammation in Ischemic Heart Failure：Role of Soluble Epoxide Hydrolase [J]. Antioxid Redox Signal，2019，31（1）：39-58.
[24] 郑精选，林进光，陈志强，等.老年急性脑梗死患者血清同型半胱氨酸水平与心房颤动并发的相关性[J].中国当代医药，2021，28（10）：23-27.
[25] 梁蔚蔚，李晓波，谢卓君.超敏C反应蛋白、同型半胱氨酸、总胆红素、尿酸水平与复发性脑梗死的相关性分析[J].中外医学研究，2021，19（14）：57-60.
[26] Rong H，Huang L，Jin N，et al. Elevated Homocysteine Levels Associated with Atrial Fibrillation and Recurrent Atrial Fibrillation [J]. Int Heart J，2020，61（4）：705-712.
[27] 孙婷婷，陈梦宇，吴大鹏，等.老年高血压合并不同类型心房颤动患者心脏结构变化及其相关因素分析[J].中华老年心脑血管病杂志，2021，23（8）：803-806.
[28] 陈伟刚，张守彦，谷云飞，等.血清同型半胱氨酸、射血分数及左房容积指数与心房颤动射频消融术后复发的相关性研究[J].中国循证心血管医学杂志，2021，13（4）：421-424. |
|
|
|
